These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32695671)

  • 1. A Novel Prediction Tool Based on Large Cohorts to Determine the Cancer-Specific Survival Probability of Patients With Locally Advanced Pancreatic Cancer After Irreversible Electroporation Treatment.
    He C; Huang X; Zhang Y; Lin X; Li S
    Front Oncol; 2020; 10():952. PubMed ID: 32695671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer.
    He C; Huang X; Zhang Y; Cai Z; Lin X; Li S
    Front Oncol; 2020; 10():6. PubMed ID: 32038984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery.
    He C; Zhang Y; Cai Z; Lin X
    BMC Cancer; 2019 Feb; 19(1):178. PubMed ID: 30813928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram to Predict Cancer-Specific Survival in Patients with Pancreatic Acinar Cell Carcinoma: A Competing Risk Analysis.
    He C; Zhang Y; Cai Z; Duan F; Lin X; Li S
    J Cancer; 2018; 9(22):4117-4127. PubMed ID: 30519311
    [No Abstract]   [Full Text] [Related]  

  • 5. Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment.
    He C; Sun S; Zhang Y; Lin X; Li S
    Front Oncol; 2020; 10():590. PubMed ID: 32426278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Model to Predict Cancer-Specific Survival for Patients With Gallbladder Carcinoma After Surgery: A Population-Based Analysis.
    He C; Cai Z; Zhang Y; Lin X
    Front Oncol; 2019; 9():1329. PubMed ID: 31921622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis.
    He C; Zhang Y; Cai Z; Lin X; Li S
    J Cancer; 2018; 9(17):3156-3167. PubMed ID: 30210639
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of Circulating Biomarkers and Construction of a Prognostic Signature for Survival Prediction in Locally Advanced Pancreatic Cancer After Irreversible Electroporation.
    He C; Sun S; Zhang Y; Li S
    J Inflamm Res; 2021; 14():1689-1699. PubMed ID: 33953596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of surgery in metastatic pancreatic neuroendocrine tumors: a competing risk analysis.
    He CB; Zhang Y; Cai ZY; Lin XJ
    Endocr Connect; 2019 Mar; 8(3):239-251. PubMed ID: 30726772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Score for the Survival Probability of Patients With Orbital Rhabdomyosarcoma After Surgery: A Long-Term and Large Cohort Study.
    Zhang Y; He C; Lian Y; Xiao H
    Front Oncol; 2020; 10():1590. PubMed ID: 32974196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer.
    He C; Sun S; Zhang Y; Li S
    J Inflamm Res; 2021; 14():4795-4807. PubMed ID: 34584438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis.
    He C; Wang J; Sun S; Zhang Y; Lin X; Lao X; Cui B; Li S
    BMC Cancer; 2019 Apr; 19(1):394. PubMed ID: 31029111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer.
    He C; Sun S; Huang X; Zhang Y; Lin X; Li S
    Front Oncol; 2020; 10():622318. PubMed ID: 33604301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer.
    He C; Wang J; Sun S; Zhang Y; Li S
    J Oncol; 2019; 2019():9346017. PubMed ID: 31214261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the efficacy of irreversible electroporation and conversional resection for locally advanced pancreatic cancer].
    He CB; Wang J; Mao YZ; Lao XM; Li SP
    Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):948-954. PubMed ID: 36207984
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and external validation of prognostic nomograms in hepatocellular carcinoma patients: a population based study.
    Xiao Z; Yan Y; Zhou Q; Liu H; Huang P; Zhou Q; Lai C; Zhang J; Wang J; Mao K
    Cancer Manag Res; 2019; 11():2691-2708. PubMed ID: 31118768
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
    Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
    Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open irreversible electroporation for isolated local recurrence of pancreatic ductal adenocarcinoma after primary surgery.
    Heger U; Mack C; Tjaden C; Pan F; Pausch T; Hinz U; Sommer CM; Hackert T
    Pancreatology; 2021 Oct; 21(7):1349-1355. PubMed ID: 34404600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combining intraoperative ultrasound-guided irreversible electroporation with chemotherapy for treating locally advanced pancreatic cancer: a clinical report of 64 cases].
    Li SP; He CB; Wang J; Mao YZ; Lao XM; Cui BK; Lin XJ
    Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):787-792. PubMed ID: 32993267
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival.
    Woeste MR; Wilson KD; Kruse EJ; Weiss MJ; Christein JD; White RR; Martin RCG
    Front Oncol; 2021; 11():817220. PubMed ID: 35096621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.